Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by Aprilstocksgoupon Nov 28, 2022 1:50pm
174 Views
Post# 35134377

Thanks for the welcome noteable

Thanks for the welcome noteablei was surprised yours was a real account --i thought i was just some auto stockhouse thing by the vast number of posts that seem to be spamming the page from your handle.  I see now that you are making predictions for an 8 billion dollar acquisition.  Well certainly those predictions are welcome if supported with some facts.   Not sure what a barking dog is but a friend of mine tipped me to this a few weeks ago and just got around to looking into it.  I have a small position 10k shares.  But will add if it continues to seem promising.  One thing that is distressing is that some intelligent posters here are being ripped to shreads simply for raising some concerns about the company---Quentin in particular --who appears to be a legit longterm investor.  i ignore the likes of Buck henry or Callahan though Callahans vietnam quagmire analogy did make me chuckle - - i suppose those who have been here for 20 plus years are getting weary ---imagine if they had put their money in Amazon instead..  I appreciate the concerns of all as I try to learn more.  But tne comments of noteable and fox make me worry that this stock has developed a cult following where dissent of any kind is not tolerated. In my view that diminishes the impact of the many positive comments posted here.  I think concerns about the stock volume are legitimate given the recent studies and BP cooperation.  You would think the news would be driving more interest but I can see how a company that has been around for 20 years could be off the radar- And the biotech area is getting hammered across the board.  I look forward to the meeting of December 6-7
<< Previous
Bullboard Posts
Next >>